Yahoo Web Search

Search results

  1. www.ncbi.nlm.nih.gov › books › NBK584477Scleroderma

    May 24, 2022 · SUMMARY. Systemic sclerosis, also called scleroderma, is a complex, multisystem rheumatic condition which has high variability in disease presentation and trajectory. It is characterized by immune dysregulation, vasculopathy, and progressive fibrosis that typically affects the skin and internal organs.

    • 2022/05/24
  2. May 1, 2005 · In this second edition of The Scleroderma Book, Dr Maureen Mayes—the leading authority in the field—draws on her extensive experience treating scleroderma to provide up-to-date, practical information that will help patients manage their symptoms and improve their quality of life.

  3. People also ask

  4. Apr 2, 2016 · The journal publishes high quality, original research articles on the epidemiology, natural history, pathophysiology, diagnosis, treatment and outcome of these diseases. View full journal description. This journal is a member of the Committee on Publication Ethics (COPE).

  5. Overview. Editors: Yannick Allanore, John Varga, Christopher P. Denton, Masataka Kuwana, Lorinda Chung, Ami A. Shah. Fully updated third edition. Provides a concise synthesis of pathogenesis and modern approaches to management of systemic sclerosis. Presents an integrated multidisciplinary approach to comprehensive patient care. 241 Accesses.

  6. May 5, 2021 · Therapeutic options for systemic sclerosis–related cutaneous disease. New trials and increased understanding of pathogenesis have produced a number of promising therapies for SSc-related skin disease (Table 1). Each of these may be considered depending on SSc subtype, status of extracutaneous organ involvement, and stage of evolution of skin ...

    • Jane L Zhu, Samantha M Black, Henry W Chen, Heidi T Jacobe
    • 10.12703/r/10-43
    • 2021
    • Fac Rev. 2021; 10: 43.
  7. The Scleroderma Research Foundation funds research aimed at understanding the pathogenesis of scleroderma and promoting the design, development, and pilot-testing of hypothesis-driven, innovative, therapeutic approaches.

  8. Mar 6, 2024 · Hayakazu Sumida. Research Open Access 06 Mar 2024 Scientific Reports. Volume: 14, P: 5572. GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor...

  1. People also search for